Continuous Bioprocessing Market Intelligence Report - Global Forecast to 2027

Continuous Bioprocessing Market Intelligence Report - Global Forecast to 2027

The Global Continuous Bioprocessing Market is projected to reach USD 18,067.04 million by 2027 from USD 8,795.43 million in 2021, at a CAGR 12.74% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Continuous Bioprocessing Market size was estimated at USD 3,142.53 million in 2021 and expected to reach USD 3,517.99 million in 2022, at a CAGR 12.52% to reach USD 6,380.45 million by 2027.
• The Asia-Pacific Continuous Bioprocessing Market size was estimated at USD 2,190.13 million in 2021 and expected to reach USD 2,477.32 million in 2022, at a CAGR 12.91% to reach USD 4,538.40 million by 2027.
• The Europe, Middle East & Africa Continuous Bioprocessing Market size was estimated at USD 3,462.76 million in 2021 and expected to reach USD 3,909.21 million in 2022, at a CAGR 12.83% to reach USD 7,148.17 million by 2027.

Market Segmentation & Coverage:

The report on continuous bioprocessing identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the continuous bioprocessing to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

• Bioreactors
• Cell Culture Media & Reagent
• Centrifuges
• Chromatography System & Consumable
• Filtration Systems and Consumables
• Incubators & Shakers
• Mixing Systems

End-User:

• Academic & Research Institutes
• Contract Development & Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Application:

• Commercial
  • Cell & Gene Therapy Production
  • Monoclonal Antibodies Production
  • Plasma Fractionation
  • Recombinant Protein Production
  • Vaccine Manufacturing
• Research & Development

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• 3M Company
• Applikon Biotechnology B.V.
• Bio-Rad Laboratories, Inc.
• Bionet
• Colder Products Company
• Danaher Corporation
• Eppendorf AG
• Fujifilm Holdings Corporation
• GE Healthcare
• Lonza Group
• Merck KGaA
• Repligen Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Watson-Marlow Fluid Technology Group
• WuXi Biologics

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 8,795.43 million

Estimated Year Value: USD 9,904.53 million

Forecast Year Value: USD 18,067.04 million

CAGR (%): 12.74%.

Please Note: PDF & Excel + Online Access - 1 Year